Novel synergistic antibiofilm combinations for salvage of infected catheters

Journal of Medical Microbiology

Volumn 58, Issue 7, 2009, Pages 936-944

  Venkatesh, Mohan ^a   Rong, Liang ^a   Raad, Issam ^b   Versalovic, James ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; AMPHOTERICIN B; EDETIC ACID; FLUCONAZOLE; LACTOFERRIN; NAFCILLIN; TALACTOFERRIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; BIOMASS; CANDIDA ALBICANS; CATHETER INFECTION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG POTENTIATION; HEALTH CARE COST; HUMAN; ISOLATED ORGAN; MICROTITER PLATE ASSAY; MORBIDITY; MORTALITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFECTIVE AGENTS; BIOFILMS; CANDIDA ALBICANS; CATHETERS, INDWELLING; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MICROSCOPY, CONFOCAL; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 67650188164     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.009761-0     Document Type: Article

References (57)

1. Alem, M. A. & Douglas, L. J. (2005). Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54, 1001-1005. (Pubitemid 41566768)
2. Almuneef, M. A., Memish, Z. A., Balkhy, H. H., Hijazi, O., Cunningham, G. & Francis, C. (2006). Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J Hosp Infect 62, 207-213. (Pubitemid 43056663)
3. Anaissie, E., Samonis, G., Kontoyiannis, D., Costerton, J., Sabharwal, U., Bodey, G. & Raad, I. (1995). Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 14, 134-137.
4. Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K. & Pitula, A. (2004). Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72, 6023-6031. (Pubitemid 39303717)
5. Bachmann, S. P., Ramage, G., VandeWalle, K., Patterson, T. F., Wickes, B. L. & Lopez-Ribot, J. L. (2003). Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother 47, 3657-3659. (Pubitemid 37345743)
6. Broom, J., Woods, M., Allworth, A., McCarthy, J., Faoagali, J., Macdonald, S. & Pithie, A. (2008). Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis 40, 399-406. (Pubitemid 351566567)
7. Cerca, N., Pier, G. B., Vilanova, M., Oliveira, R. & Azeredo, J. (2004). Influence of batch or fed-batch growth on Staphylococcus epidermidis biofilm formation. Lett Appl Microbiol 39, 420-424. (Pubitemid 39421148)
8. Cerca, N., Martins, S., Cerca, F., Jefferson, K. K., Pier, G. B., Oliveira, R. & Azeredo, J. (2005). Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 56, 331-336. (Pubitemid 41158521)
9. Chambers, S. T., Peddie, B. & Pithie, A. (2006). Ethanol disinfection of plastic-adherent micro-organisms. J Hosp Infect 63, 193-196.
10. Chou, T. C. (2006). Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58, 621-681. (Pubitemid 44403686)
11. Chou, T. C. & Talalay, P. (1984). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22, 27-55.
12. CLSI (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, approved standard, 2nd edn, M27-A2. Wayne, PA: CLSI.
13. CLSI (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, approved standard, 6th edn, M7-A7. Wayne, PA: CLSI.
14. CLSI (2007). Performance Standards for Antimicrobial Susceptibility Testing, 17th informational supplement, M100-S17.27. Wayne, PA: CLSI.
15. Console, G., Calabro, C., Nardulli, P., Digiuseppe, F., Rucci, A., Russo, P. & Geppetti, P. (2007). Clinical and economic effects of central venous catheters on oncology patient care. J Chemother 19, 309-314. (Pubitemid 47075127)
16. Crnich, C. J., Halfmann, J. A., Crone, W. C. & Maki, D. G. (2005). The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol 26, 708-714. (Pubitemid 41169741)
17. Dimick, J. B., Pelz, R. K., Consunji, R., Swoboda, S. M., Hendrix, C. W. & Lipsett, P. A. (2001). Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 136, 229-234. (Pubitemid 32143849)
18. Domingue, G., Ellis, B., Dasgupta, M. & Costerton, J. W. (1994). Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards. J Clin Microbiol 32, 2564-2568. (Pubitemid 24284665)
19. Donelli, G. (2006). Vascular catheter-related infection and sepsis. Surg Infect (Larchmt) 7 (Suppl. 2), S25-S27.
20. Faix, R. G. & Kovarik, S. M. (1989). Polymicrobial sepsis among intensive care nursery infants. J Perinatol 9, 131-136.
21. Furuya, E. Y. & Lowy, F. D. (2003). Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Curr Opin Pharmacol 3, 464-469. (Pubitemid 37221124)
22. Gandelman, G., Frishman, W. H., Wiese, C., Green-Gastwirth, V., Hong, S., Aronow, W. S. & Horowitz, H. W. (2007). Intravascular device infections: epidemiology, diagnosis, and management. Cardiol Rev 15, 13-23. (Pubitemid 46005944)
23. Gil, M. L., Casanova, M. & Martinez, J. P. (1994). Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA. Arch Microbiol 161, 489-494. (Pubitemid 24192015)
24. Gordon, C. A., Hodges, N. A. & Marriott, C. (1991). Use of slime dispersants to promote antibiotic penetration through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother 35, 1258-1260.
25. Hawser, S. P., Norris, H., Jessup, C. J. & Ghannoum, M. A. (1998). Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 36, 1450-1452. (Pubitemid 28208050)
26. Heydorn, A., Nielsen, A. T., Hentzer, M., Sternberg, C., Givskov, M., Ersboll, B. K. & Molin, S. (2000). Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146, 2395-2407. (Pubitemid 30806650)
27. Karlowicz, M. G., Hashimoto, L. N., Kelly, R. E., Jr & Buescher, E. S. (2000). Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 106, E63.
28. Kaufman, D. & Fairchild, K. D. (2004). Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 17, 638-680. (Pubitemid 38970686)
29. Leitch, E. C. & Willcox, M. D. (1999a). Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Curr Eye Res 19, 12-19. (Pubitemid 29308824)
30. Leitch, E. C. & Willcox, M. D. (1999b). Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol 48, 867-871. (Pubitemid 29476423)
31. Levy, S. B. (1998). Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment. BMJ 317, 612-613.
32. Marchese, A., Bozzolasco, M., Gualco, L., Debbia, E. A., Schito, G. C. & Schito, A. M. (2003). Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents 22 (Suppl. 2), 95-100. (Pubitemid 37188493)
33. Martinez-Irujo, J. J., Villahermosa, M. L., Alberdi, E. & Santiago, E. (1996). A checkerboard method to evaluate interactions between drugs. Biochem Pharmacol 51, 635-644. (Pubitemid 26079334)
34. McKenzie, F. E. (2006). Case mortality in polymicrobial bloodstream infections. J Clin Epidemiol 59, 760-761. (Pubitemid 43825725)
35. Mouw, E., Chessman, K., Lesher, A. & Tagge, E. (2008). Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg 43, 1025-1029. (Pubitemid 351814902)
36. Noyola, D. E., Fernandez, M., Moylett, E. H. & Baker, C. J. (2001). Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 32, 1018-1023. (Pubitemid 32299636)
37. O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A. & other authors (2002). Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 30, 476-489.
38. Olofsson, A. C., Hermansson, M. & Elwing, H. (2003). N-Acetyl-Lcysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol 69, 4814-4822. (Pubitemid 36992945)
39. Ozerdem Akpolat, N., Elci, S., Atmaca, S., Akbayin, H. & Gul, K. (2003). The effects of magnesium, calcium and EDTA on slime production by Staphylococcus epidermidis strains. Folia Microbiol (Praha) 48, 649-653. (Pubitemid 38038829)
40. Pawar, M., Mehta, Y., Kapoor, P., Sharma, J., Gupta, A. & Trehan, N. (2004). Central venous catheter-related blood stream infections: incidence, risk factors, outcome, and associated pathogens. J Cardiothorac Vasc Anesth 18, 304-308. (Pubitemid 38844746)
41. Percival, S. L., Kite, P., Eastwood, K., Murga, R., Carr, J., Arduino, M. J. & Donlan, R. M. (2005). Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26, 515-519. (Pubitemid 40896140)
42. Perez-Giraldo, C., Rodriguez-Benito, A., Moran, F. J., Hurtado, C., Blanco, M. T. & Gomez-Garcia, A. C. (1997). Influence of Nacetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother 39, 643-646. (Pubitemid 27236884)
43. Raad, I. I. & Hanna, H. A. (2002). Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 162, 871-878. (Pubitemid 34299118)
44. Raad, I., Chatzinikolaou, I., Chaiban, G., Hanna, H., Hachem, R., Dvorak, T., Cook, G. & Costerton, W. (2003). In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47, 3580-3585.
45. Raad, I., Hanna, H., Dvorak, T., Chaiban, G. & Hachem, R. (2007a). Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51, 78-83. (Pubitemid 46047690)
46. Raad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R. & Hachem, R. (2007b). Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin- resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51, 1656-1660. (Pubitemid 46744141)
47. Ramage, G. & Lopez-Ribot, J. L. (2005). Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med 118, 71-79.
48. Ramage, G., Wickes, B. L. & Lopez-Ribot, J. L. (2007). Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia 164, 301-306. (Pubitemid 47622130)
49. Rello, J., Ochagavia, A., Sabanes, E., Roque, M., Mariscal, D., Reynaga, E. & Valles, J. (2000). Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162, 1027-1030.
50. Root, J. L., McIntyre, O. R., Jacobs, N. J. & Daghlian, C. P. (1988). Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 32, 1627-1631. (Pubitemid 18267605)
51. Schinabeck, M. K., Long, L. A., Hossain, M. A., Chandra, J., Mukherjee, P. K., Mohamed, S. & Ghannoum, M. A. (2004). Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48, 1727-1732. (Pubitemid 38544381)
52. Singh, P. K. (2004). Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. Biometals 17, 267-270. (Pubitemid 38987148)
53. Singh, P. K., Parsek, M. R., Greenberg, E. P. & Welsh, M. J. (2002). A component of innate immunity prevents bacterial biofilm development. Nature 417, 552-555. (Pubitemid 34595922)
54. Stoodley, P., Wilson, S., Hall-Stoodley, L., Boyle, J. D., Lappin-Scott, H. M. & Costerton, J. W. (2001). Growth and detachment of cell clusters from mature mixed-species biofilms. Appl Environ Microbiol 67, 5608-5613. (Pubitemid 33640996)
55. Valenti, P. & Antonini, G. (2005). Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 62, 2576-2587. (Pubitemid 41721231)
56. Venkatesh, M. P. & Liang, R. (2008). Human recombinant lactoferrin is synergistic with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis. J Med Microbiol 57, 1113-1121.
57. Xu, Y. Y., Samaranayake, Y. H., Samaranayake, L. P. & Nikawa, H. (1999). In vitro susceptibility of Candida species to lactoferrin. Med Mycol 37, 35-41.